Hims & Hers Health HIMS
NYSE HIMS
$31.84 +0.75 (+2.41%)
As of: Aug 20, 2026 · 3:59 PM EDT

Hims & Hers Health (HIMS) Cash from Investing Activities (2019 - 2026)

Hims & Hers Health (HIMS) posted Cash from Investing Activities of -$15.4 million for Q1 2026, up 81.54% sequentially from -$83.7 million in Q4 2025, and up 52.9% YoY from -$10.1 million in Q1 2025.

Hims & Hers Health (HIMS) Cash from Investing Activities (2019 - 2026) Analysis & Trends

Hims & Hers Health has reported Cash from Investing Activities for 8 years, with the latest figure at -$15.4 million in Q1 2026.

  • Quarterly Cash from Investing Activities rose 52.9% year-over-year to -$15.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.0 billion (down 1452.89% YoY) and the FY2025 annual result came in at -$1.0 billion, down 5280.92% from the prior year.
  • Cash from Investing Activities climbed to -$15.4 million in Q1 2026 per HIMS's latest filing, from -$83.7 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $20.7 million in Q4 2023 and troughed at -$887.4 million in Q3 2025.
  • A 5-year average of -$61.0 million and a median of -$4.5 million in 2024 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities soared 417.09% in 2024, then slumped 8421.2% in 2025.
  • Over 5 years, Cash from Investing Activities stood at $6.0 million in 2022, then surged by 244.74% to $20.7 million in 2023, then tumbled by 183.14% to -$17.2 million in 2024, then plunged by 386.32% to -$83.7 million in 2025, then jumped by 81.54% to -$15.4 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$15.4 million, -$83.7 million, and -$887.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -491.00 Mn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -300.00 Mn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -550.24 Mn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 87.50 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -51.60 Mn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -135.40 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -110.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Hims & Hers Health 7.42 Bn 6.57 Bn 480.80 Mn 84.54 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 84.54 Mn
Jun 30, 2026 84.54 Mn
Mar 31, 2026 -15.45 Mn
Mar 31, 2026 -15.45 Mn
Dec 31, 2025 -83.68 Mn
Dec 31, 2025 -83.68 Mn
Sep 30, 2025 -887.40 Mn
Sep 30, 2025 -887.40 Mn
Jun 30, 2025 -21.09 Mn
Jun 30, 2025 -21.09 Mn
Mar 31, 2025 -32.80 Mn
Mar 31, 2025 -32.80 Mn
Dec 31, 2024 -17.21 Mn
Dec 31, 2024 -17.21 Mn
Sep 30, 2024 -10.41 Mn
Sep 30, 2024 -10.41 Mn
Jun 30, 2024 -4.47 Mn
Jun 30, 2024 -4.47 Mn
Mar 31, 2024 13.04 Mn
Mar 31, 2024 13.04 Mn